Evidence map›Paper›PMID 21901347›Full record

ReviewRheumatology international2012

Bone marrow lesions: a universal bone response to injury?

Erik Fink Eriksen, Johan Diederich Ringe

Abstract readReview
PubMed Publisher
In one paragraph

Review in Rheumatology international, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Clinical performance of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Review
  3. Article
  4. [Etiology of osteonecrosis and bone marrow edema].Orthopadie (Heidelberg, Germany) · 2025
    Review
  5. Article
  6. Article
  7. Bone marrow edema of the hip: a narrative review.Archives of orthopaedic and trauma surgery · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Percutaneous Skeletal Fixation of Painful Subchondral Bone Marrow Edema of the Knee.Arthroscopy, sports medicine, and rehabilitation · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Erik Fink EriksenDepartment of Endocrinology, Oslo University Hospital, P.O. Box 4956 Nydalen, 0424 Oslo, Norway. e.f.eriksen@medisin.uio
Johan Diederich Ringe

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ever increasing use of magnetic resonance imaging in clinical practice has led to the recognition of a new entity, bone marrow lesions (BMLs). These lesions are characterized by excessive water signals in the marrow space and have emerged as a central component of many different diseases affecting the musculoskeletal system. BMLs have in particular been associated with a wide variety of inflammatory and non-inflammatory rheumatologic conditions and are not only considered significant sources of pain, but also linked to the worsening of patient prognosis in many disease states. In this review, we summarize the current knowledge on BMLs with an emphasis on the clinical and histological features of this entity in inflammatory and non-inflammatory disease and provide a unifying hypothesis based on the appearance with various imaging technologies. We also try to pair this hypothesis with the apparent beneficial effects of various treatment regimens, mainly within the group of bone antiresorptive drugs (calcitonin, bisphosphonates) on symptoms associated with BMLs.

Indexed as

Bone Density Conservation AgentsBone MarrowBone Marrow DiseasesCalcitoninDiphosphonatesFemaleHumansMagnetic Resonance ImagingMalePrognosisTreatment OutcomeUltrasonographyWounds and InjuriesBone Density Conservation AgentsCalcitoninDiphosphonates

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.